6D 那个650刀的REBATE搞起来一头雾水# PhotoGear - 摄影器材
a*h
1 楼
MM的平均成本是4－4.5. MM只有一个，Bruce Kovner 的Caxton Associates. 过去几个
月换手频繁。
月换手频繁。
a*g
2 楼
REBATE FORM 写的含含糊糊的。
a*h
3 楼
Synta Announces Appointment of Steven Bernitz as Senior Vice President,
Corporate Development
此人历史上有数次Deal Making的成功纪录。看来该公司应该有一些想法和动作了。
Corporate Development
此人历史上有数次Deal Making的成功纪录。看来该公司应该有一些想法和动作了。
w*e
4 楼
这是个什么股。看起来要突破了。
基本面如何？
【在 a****h 的大作中提到】
: MM的平均成本是4－4.5. MM只有一个，Bruce Kovner 的Caxton Associates. 过去几个
: 月换手频繁。
基本面如何？
【在 a****h 的大作中提到】
: MM的平均成本是4－4.5. MM只有一个，Bruce Kovner 的Caxton Associates. 过去几个
: 月换手频繁。
a*h
5 楼
对于小药股，如果不是公司内部人士，所有的FA都是野鸡FA. 我们只能从外部管窥一二
。对于这个新HIRED 家伙，他的简历如下：
• Accomplished biopharma dealmaker and strategist with a proven track
record of success in business development and executive management
• Led the initiation, negotiation and management of two of biotech’s
largest licensing transactions (Concert-GSK in 2009 for $1B and Coley-Pfizer
in 2005 for $600MM) -- both of which were nominated for several “Deal of
the Year” awards
• Closed numerous transactions across a wide array of deal structures,
development stages, indications, and modalities
Specialties: Structuring and negotiating business collaborations for life
science companies; Out-licensing biopharmaceutical products; In-licensing
life science technologies; Strategic/ business planning in life sciences;
Evaluating potential venture investments
公司最大股东KOVNER，这个老犹太只能以老奸巨猾来形容。
Kovner's first trade was in 1977 for $3,000, borrowed against his MasterCard
, in soybean futures contracts. Realizing growth to $40,000, he then watched
the contract drop to $23,000 before selling.[5] He later claimed that this
first, nerve-racking trade taught him the importance of risk management.
In his eventual role as a trader under Michael Marcus at Commodities
Corporation (now part of Goldman Sachs), he purportedly made millions and
gained widespread respect as an objective and sober trader.[2] This
ultimately led to the establishment of his current company, Caxton
Associates, in 1983, which at its peak managed over $10 billion in capital
and has been closed to new investors since 1992. Kovner is a director of
Synta Pharmaceuticals since 2002.[8]
Kovner is not well known outside of professional circles. He has very rarely
given interviews and is notoriously private. His Fifth Avenue mansion in
New York City, the Willard D. Straight House, features a lead-lined room to
protect against a chemical, biological, or dirty bomb attack.[2]
需要注意的是，这个股有太多年底拉升过了年很砸的恶劣纪录。所以切记设好止损！！
。对于这个新HIRED 家伙，他的简历如下：
• Accomplished biopharma dealmaker and strategist with a proven track
record of success in business development and executive management
• Led the initiation, negotiation and management of two of biotech’s
largest licensing transactions (Concert-GSK in 2009 for $1B and Coley-Pfizer
in 2005 for $600MM) -- both of which were nominated for several “Deal of
the Year” awards
• Closed numerous transactions across a wide array of deal structures,
development stages, indications, and modalities
Specialties: Structuring and negotiating business collaborations for life
science companies; Out-licensing biopharmaceutical products; In-licensing
life science technologies; Strategic/ business planning in life sciences;
Evaluating potential venture investments
公司最大股东KOVNER，这个老犹太只能以老奸巨猾来形容。
Kovner's first trade was in 1977 for $3,000, borrowed against his MasterCard
, in soybean futures contracts. Realizing growth to $40,000, he then watched
the contract drop to $23,000 before selling.[5] He later claimed that this
first, nerve-racking trade taught him the importance of risk management.
In his eventual role as a trader under Michael Marcus at Commodities
Corporation (now part of Goldman Sachs), he purportedly made millions and
gained widespread respect as an objective and sober trader.[2] This
ultimately led to the establishment of his current company, Caxton
Associates, in 1983, which at its peak managed over $10 billion in capital
and has been closed to new investors since 1992. Kovner is a director of
Synta Pharmaceuticals since 2002.[8]
Kovner is not well known outside of professional circles. He has very rarely
given interviews and is notoriously private. His Fifth Avenue mansion in
New York City, the Willard D. Straight House, features a lead-lined room to
protect against a chemical, biological, or dirty bomb attack.[2]
需要注意的是，这个股有太多年底拉升过了年很砸的恶劣纪录。所以切记设好止损！！
c*w
6 楼
尝试把这两个放在一起。
c*w
7 楼
说不定会到4块钱再去一下，？
它去4块钱我也准备in
【在 c****w 的大作中提到】
: 尝试把这两个放在一起。
它去4块钱我也准备in
【在 c****w 的大作中提到】
: 尝试把这两个放在一起。
w*e
8 楼
有一个很重要的区别。 SNTA似乎有增量资金进场。 但PSUN没有。
【在 c****w 的大作中提到】
: 尝试把这两个放在一起。
【在 c****w 的大作中提到】
: 尝试把这两个放在一起。
c*w
9 楼
是的。volume是一个很大的区别。不过一个是周线图，另外一个是日线图，还是有些影
响的。
另外服装股和医药股不一样的地方在于，服装股和它数据的fa等等还是比较挂钩的，纯
炒作非常困难。
【在 w*******e 的大作中提到】
: 有一个很重要的区别。 SNTA似乎有增量资金进场。 但PSUN没有。
响的。
另外服装股和医药股不一样的地方在于，服装股和它数据的fa等等还是比较挂钩的，纯
炒作非常困难。
【在 w*******e 的大作中提到】
: 有一个很重要的区别。 SNTA似乎有增量资金进场。 但PSUN没有。
w*e
10 楼
那再好不过。如果它能回到支撑附件。
看样子不太可能。
【在 c****w 的大作中提到】
: 说不定会到4块钱再去一下，？
: 它去4块钱我也准备in
看样子不太可能。
【在 c****w 的大作中提到】
: 说不定会到4块钱再去一下，？
: 它去4块钱我也准备in
c*w
11 楼
要相信股市是一个化腐朽为神奇的地方...
【在 w*******e 的大作中提到】
: 那再好不过。如果它能回到支撑附件。
: 看样子不太可能。
【在 w*******e 的大作中提到】
: 那再好不过。如果它能回到支撑附件。
: 看样子不太可能。
相关阅读
终于把女儿哄睡觉了预计要有一波D3/D3x的deal了canon 35mm f1.4 vs Rokinon 35mm f1.4canon 18-200mmor 18-135mm,一镜走天下。去了趟巧克力工厂，发现印度人都用Canon这个还行吧？ HP ProLiant Microserver $115【视屏】绝对的N黑C白的对决。sigma 70-200/2.8 OS 这个镜头怎么样？D90在buy.com上829算好DEAL吗？冷死了zz 结婚五个月小三逼死原配政府太黑了记者脑子思维一定要快GS和JPM在普林斯顿的recruiting event被crash了，哈哈 (转载)第一次拆pro 9000 II mark II拍娃的都来这里学习吧，器材手法都很简单amazon真舍得啊碰到一个会讲中文的老美买家[求购] CANON printer pro9000 markII anywhere @175 (转载)Canon的G12好吗